News
We recruit a Group leader in Integrative Structural Biology
The IPBS-Toulouse launches its annual call for the recruitment of new group leaders. As a leading research institute of the
30 November 2023
Home
IPBS
Toulouse
Better understanding towards better therapeutics in Cancer, Infection and Inflammation.
News
Jean-Philippe Girard is Highly Cited Researcher 2023 in the Immunology category
Jean-Philippe Girard, Senior Research Director at Inserm, ranks among the world’s most cited scientists in the prestigious ‘Highly Cited Researchers
15 November 2023
Press releases
IP6: an endogenous small molecule which promotes DNA repair
IP6, inositol hexaphosphate or phytic acid, is a product of cellular metabolism that binds to numerous proteins whose functions it
15 November 2023
Press releases
Marine sponges inspire a new family of anticancer agents
A new generation of potential anticancer agents has been developed jointly by three labs in Toulouse. These molecules, which were
17 October 2023
Agenda
Isabelle Laplace - Faut-il arrêter de prendre l’avion ?
Fernand Gallais Conference room
Dr. Jani Bolla - Next-generation antibiotics: Exploring the bacterial cell envelope for new targets
IPBS-Toulouse, Seminar room
Anti-cancer immunity and immunotherapies
Fernand Gallais Conference room
PhD Thesis defense - Ms Estefania Vina-Barrientos
Fernand Gallais Conference room
Featured publications (2022-2023)
Pinilla et al. (2023) EEF2-inactivating toxins engage the NLRP1 inflammasome and promote epithelial barrier disruption. J Exp Med 220(10): e20230104
Mascarau et al. (2023) Productive HIV-1 infection of tissue macrophages by fusion with infected CD4+ T cells. J Cell Biol 222: e202205103
Viljoen*, Vercellone* et al. (2023) Nanoscale clustering of mycobacterial ligands and DC-SIGN host receptors are key determinants for pathogen recognition. Sci Adv 9(20): eadf9498
Seif-El-Dahan*, Kefala-Stavridi*, Frit*, Hardwick* et al. (2023) PAXX binding to the NHEJ machinery explains functional redundancy with XLF. Sci Adv 9(22): eadg2834
Voisinne*, Locard-Paulet* et al. (2022) Kinetic proofreading through the multi-step activation of the ZAP70 kinase underlies early T cell ligand discrimination. Nat Immunol 23:1355-1364
Boudehen*, Faucher* et al. (2022) Mycobacterial resistance to zinc poisoning requires assembly of P-ATPase-containing membrane metal efflux platforms. Nat Commun 13: 4731
Mosquera-Restrepo et al. (2022) A M. tuberculosis fingerprint in human breath allows tuberculosis detection. Nat Commun 13: 7751
Planès*, Pinilla*, Santoni*, Hessel*, Passemar* et al. (2022) Human NLRP1 is a sensor of pathogenic coronavirus 3CL proteases in lung epithelial cells. Mol Cell 82: 2385-2400.e9
Asrir*, Tardiveau*, Coudert*, Laffont*, Blanchard* et al. (2022) Tumor-associated high endothelial venules mediate lymphocyte entry into tumors and predict response to PD-1 plus CTLA-4 combination immunotherapy. Cancer Cell 40: 318-334.e9
Demange*, Joly*, Marcoux* et al. (2022) SDR enzymes oxidize specific lipidic alkynylcarbinols into cytotoxic protein-reactive species. Elife 11: e73913
Kefala-Stavridi*, Gontier*, Morin*, Frit* et al. (2023) Structural and functional basis of inositol hexaphosphate stimulation of NHEJ through stabilization of Ku-XLF interaction. Nucleic Acids Res Oct 23:gkad863
About
the IPBS
The IPBS is a joint research center of the CNRS and the University of Toulouse. Occupying 12,000 m2 in the heart of the main campus of the University of Toulouse III-Paul Sabatier, which offers high-level multidisciplinary training in the fields of science, health and engineering, the IPBS is part of one of the most important scientific research poles in health and biological sciences in France.
0
Staff
0
Research teams
0
CNRS International Actions
0
running
European grants
European grants
0
Nationalities
0
M2 of laboratories
You wish to work on cancer, infectious or inflammatory diseases, with cutting-edge approaches in cellular, molecular and structural biology, in a rich and stimulating environment?
Join us!
Join us!
READY TO COLLABORATE ?